The Experts below are selected from a list of 303 Experts worldwide ranked by ideXlab platform
E Harvey - One of the best experts on this subject based on the ideXlab platform.
-
Pseudoporphyria cutanea tarda two case reports on children receiving peritoneal dialysis and erythropoietin therapy
The Journal of Pediatrics, 1992Co-Authors: E Harvey, Horgan C Bell, Amy S Paller, E J LavooAbstract:Pseudoporphyria cutanea tarda occurred in two children undergoing peritoneal dialysis and receiving erythropoietin therapy. The mechanism whereby erythropoietin might lead to photosensitization is unknown, but physicians should be aware of this possible association.
Amy S Paller - One of the best experts on this subject based on the ideXlab platform.
-
Pseudoporphyria cutanea tarda two case reports on children receiving peritoneal dialysis and erythropoietin therapy
The Journal of Pediatrics, 1992Co-Authors: E Harvey, Horgan C Bell, Amy S Paller, E J LavooAbstract:Pseudoporphyria cutanea tarda occurred in two children undergoing peritoneal dialysis and receiving erythropoietin therapy. The mechanism whereby erythropoietin might lead to photosensitization is unknown, but physicians should be aware of this possible association.
Horgan C Bell - One of the best experts on this subject based on the ideXlab platform.
-
Pseudoporphyria cutanea tarda two case reports on children receiving peritoneal dialysis and erythropoietin therapy
The Journal of Pediatrics, 1992Co-Authors: E Harvey, Horgan C Bell, Amy S Paller, E J LavooAbstract:Pseudoporphyria cutanea tarda occurred in two children undergoing peritoneal dialysis and receiving erythropoietin therapy. The mechanism whereby erythropoietin might lead to photosensitization is unknown, but physicians should be aware of this possible association.
Laura Finlayson - One of the best experts on this subject based on the ideXlab platform.
-
naproxen induced Pseudoporphyria in patients with juvenile rheumatoid arthritis
The Journal of Pediatrics, 1994Co-Authors: Bianca A Lang, Laura FinlaysonAbstract:Pseudoporphyria, a cutaneous disorder characterized by skin fragility, vesiculation, and scarring, has been reported as a side effect of naproxen therapy in children with juvenile rheumatoid arthritis (JRA). We report the results of a 6-month prospective study to determine the prevalence of Pseudoporphyria in our JRA population. All the patients with Pseudoporphyria had received naproxen for ≥4 weeks at the time of the study. Of the patients treated with naproxen, 12% (9/74) developed this complication. No patient had significant elevation of free erythrocyte protoporphyrin, excluding the diagnosis of true erythropoietic protoporphyria. We conclude that Pseudoporphyria is a common side effect of naproxen therapy in children with JRA, even in geographic areas without high sun exposure. Because of the risk of facial scarring with Pseudoporphyria, physicians and parents of children with JRA should be aware of this complication.
E J Lavoo - One of the best experts on this subject based on the ideXlab platform.
-
Pseudoporphyria cutanea tarda two case reports on children receiving peritoneal dialysis and erythropoietin therapy
The Journal of Pediatrics, 1992Co-Authors: E Harvey, Horgan C Bell, Amy S Paller, E J LavooAbstract:Pseudoporphyria cutanea tarda occurred in two children undergoing peritoneal dialysis and receiving erythropoietin therapy. The mechanism whereby erythropoietin might lead to photosensitization is unknown, but physicians should be aware of this possible association.
